2Marco Pagani,Sharon Stone-Elander,Stig A.Larsson. Alternative Positron emission tomography with non-conventional positron emitters:effects of their physical properties on image quality and poten tial clinical applications. European Journal of Nuclear Medicine, 1997,24(10)?A.
3Guillaume M, Luxen A, Nebeling B, et al. Recommendations for fluorine-18 production[J]. Appl Radiat Isot, 1992, 42 : 749-762.
4Bishop A, Satyamurthy N, Bida G, et al. Metals suitable for fluorine gas target bodies: first use of aluminum for the production of [18F]F_2[J]. Nucl Med Biol, 1996, 23(3): 181-188.
5Bida GT, Ehrenkaufer RL, Wolf AP, et al. The effect of target-gas purity on the chemical form of F-18 during 18F-F_2 produvtion using the neon/fluorine target[J]. J Nucl Med,1980, 21 (8): 758-762.
6Bishop A, Satyamurthy N, Bida G, et al. Proton irradiation of [~(18)O]O_2: production of [18F]F_2 and [18F]F_2+[18F]OF_2[J]. Nucl Med Biol, 1996, 23(3): 189-199.
7Toorongian SA, Mulholland GK, Jeweet DM, et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on quaternary 4-aminopyridinium resin [J]. Nucl Med Biol, 1990, 17(3): 273-279.
8Mock BH, Winkle W and Vavrek MT. A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations[J]. Nucl Med Biol, 1997, 24(2): 193-195.
9Pickett MW, Waterstram-Rich K and Turner LW. The future of medicine technology: Are we ready for advanced practice?[J]. J Nucl Med Technol, 2001, 28: 280-286.
10Hara T, Kosaka N and Kishi H. Development of 18F-fluo-roethylcholine for cancer imaging with PET: Synthesis, biochemistry, and prostate cancer imaging[J]. J Nucl Med, 2002, 43(2): 187-199.
